KARACHI: The Customs Post Clearance Audit (PCA) Karachi has issued a contravention report against M/s Getz Pharma (Private) Limited for Rs 3.135 million tax evasion by claiming inadmissible benefits under SRO567(I)/2006.
The scrutiny of the import data revealed that M/s Getz Pharma imported consignments of “Esomerprazole Pellets” under PCT Heading 2933.3990 through MCC Preventive, Custom House. And the importer had illegally availed the benefits of concessionary rate of custom duty and income tax under the aforesaid notification.
Therefore, an amount of Rs 3.135 million has been short paid/evaded by the importers on account of custom duty and withholding tax.
Hence, the importer M/s Getz Pharma Pvt Ltd has violated the provisions of Section 32(1)(2) and (3A) of the Customs Act, 1969, Sections 3(1), section 3, 6, 7 read with section 34 of Sales Tax Act 1990 and Income Tax Ordinance 2001 punishable under clauses (1), (9) and 14 of section 156(1) of the Customs Act, 1969 punishable under section 33(5) and section 7A of the Sales Tax Act 1990 read with chapter X of the Sales Tax Special procedure Rules 2007 (special procedures for payment of sales tax by the importers ) and punishable under the relevant provisions of Income Tax Ordinance 2001.
